195 related articles for article (PubMed ID: 36835220)
1. Inhibition of Xanthine Oxidase Protects against Diabetic Kidney Disease through the Amelioration of Oxidative Stress via VEGF/VEGFR Axis and NOX-FoxO3a-eNOS Signaling Pathway.
Yang KJ; Choi WJ; Chang YK; Park CW; Kim SY; Hong YA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835220
[TBL] [Abstract][Full Text] [Related]
2. Xanthine oxidoreductase inhibition ameliorates high glucose-induced glomerular endothelial injury by activating AMPK through the purine salvage pathway.
Yang KJ; Park H; Chang YK; Park CW; Kim SY; Hong YA
Sci Rep; 2024 May; 14(1):11167. PubMed ID: 38750091
[TBL] [Abstract][Full Text] [Related]
3. Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice.
Mizuno Y; Yamamotoya T; Nakatsu Y; Ueda K; Matsunaga Y; Inoue MK; Sakoda H; Fujishiro M; Ono H; Kikuchi T; Takahashi M; Morii K; Sasaki K; Masaki T; Asano T; Kushiyama A
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546603
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db mice.
Yang KS; Lim JH; Kim TW; Kim MY; Kim Y; Chung S; Shin SJ; Choi BS; Kim HW; Kim YS; Chang YS; Kim HW; Park CW
PLoS One; 2014; 9(4):e94540. PubMed ID: 24759928
[TBL] [Abstract][Full Text] [Related]
5. The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.
Youn JY; Gao L; Cai H
Diabetologia; 2012 Jul; 55(7):2069-79. PubMed ID: 22549734
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase.
Yang KJ; Kim JH; Chang YK; Park CW; Kim SY; Hong YA
Free Radic Biol Med; 2019 Dec; 145():209-220. PubMed ID: 31560952
[TBL] [Abstract][Full Text] [Related]
7. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model.
Lee HJ; Jeong KH; Kim YG; Moon JY; Lee SH; Ihm CG; Sung JY; Lee TW
Am J Nephrol; 2014; 40(1):56-63. PubMed ID: 25034030
[TBL] [Abstract][Full Text] [Related]
8. Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats.
Shirakura T; Nomura J; Matsui C; Kobayashi T; Tamura M; Masuzaki H
Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):831-8. PubMed ID: 27198514
[TBL] [Abstract][Full Text] [Related]
9. Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
Peleli M; Zollbrecht C; Montenegro MF; Hezel M; Zhong J; Persson EG; Holmdahl R; Weitzberg E; Lundberg JO; Carlström M
Free Radic Biol Med; 2016 Oct; 99():472-484. PubMed ID: 27609225
[TBL] [Abstract][Full Text] [Related]
10. Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats.
Namai-Takahashi A; Sakuyama A; Nakamura T; Miura T; Takahashi J; Kurosawa R; Kohzuki M; Ito O
Am J Hypertens; 2019 Jan; 32(1):26-33. PubMed ID: 30277494
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of XO or NOX attenuates diethylstilbestrol-induced endothelial nitric oxide deficiency without affecting its effects on LNCaP cell invasion and apoptosis.
Youn JY; Nguyen A; Cai H
Clin Sci (Lond); 2012 Oct; 123(8):509-18. PubMed ID: 22568671
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition.
Wind S; Beuerlein K; Armitage ME; Taye A; Kumar AH; Janowitz D; Neff C; Shah AM; Wingler K; Schmidt HH
Hypertension; 2010 Sep; 56(3):490-7. PubMed ID: 20606112
[TBL] [Abstract][Full Text] [Related]
13. Increased oxidative stress in the streptozotocin-induced diabetic apoE-deficient mouse: changes in expression of NADPH oxidase subunits and eNOS.
Ding H; Hashem M; Triggle C
Eur J Pharmacol; 2007 Apr; 561(1-3):121-8. PubMed ID: 17292348
[TBL] [Abstract][Full Text] [Related]
14. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.
Schröder K; Zhang M; Benkhoff S; Mieth A; Pliquett R; Kosowski J; Kruse C; Luedike P; Michaelis UR; Weissmann N; Dimmeler S; Shah AM; Brandes RP
Circ Res; 2012 Apr; 110(9):1217-25. PubMed ID: 22456182
[TBL] [Abstract][Full Text] [Related]
15. Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats.
Serizawa K; Yogo K; Aizawa K; Tashiro Y; Ishizuka N
Cardiovasc Diabetol; 2011 Nov; 10():105. PubMed ID: 22107602
[TBL] [Abstract][Full Text] [Related]
16. VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes.
Neves KB; Rios FJ; van der Mey L; Alves-Lopes R; Cameron AC; Volpe M; Montezano AC; Savoia C; Touyz RM
Hypertension; 2018 Apr; 71(4):638-647. PubMed ID: 29483228
[TBL] [Abstract][Full Text] [Related]
17. Prorenin receptor (PRR)-mediated NADPH oxidase (Nox) signaling regulates VEGF synthesis under hyperglycemic condition in ARPE-19 cells.
Haque R; Iuvone PM; He L; Hur EH; Chung Choi KS; Park D; Farrell AN; Ngo A; Gokhale S; Aseem M; Kumar B
J Recept Signal Transduct Res; 2017 Dec; 37(6):560-568. PubMed ID: 28840773
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.
Li J; Wang JJ; Yu Q; Chen K; Mahadev K; Zhang SX
Diabetes; 2010 Jun; 59(6):1528-38. PubMed ID: 20332345
[TBL] [Abstract][Full Text] [Related]
19. Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in Ins
Itano S; Kadoya H; Satoh M; Nakamura T; Murase T; Sasaki T; Kanwar YS; Kashihara N
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F765-F772. PubMed ID: 32954851
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
